REDHILL BIOPHARMA LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4628 USD | +1.71% |
|
-2.28% | -68.30% |
| 06/05 | Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib | MT |
| 06/05 | RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| REDHILL BIOPHARMA LTD. | Biopharmaceuticals | +1.71% | -2.28% | -68.30% | -78.17% | -99.85% | 14.5M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- RDHL Stock
- Charts RedHill Biopharma Ltd.
- Comparison Chart
